On March 5, 2024, Ocular Therapeutix, Inc closed the transaction.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.085 USD | -1.38% | +28.33% | +38.12% |
Apr. 18 | Health Care Flat on Rotation From Rate-Sensitive Sectors -- Health Care Roundup | DJ |
Apr. 18 | Ocular Therapeutix Reports Positive Topline Data in Diabetic Retinopathy Trial; Shares Fall | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.12% | 955M | |
+28.50% | 662B | |
+22.23% | 546B | |
-4.93% | 359B | |
+16.97% | 323B | |
+4.08% | 289B | |
+13.68% | 234B | |
+3.84% | 198B | |
-10.35% | 194B | |
+3.98% | 167B |
- Stock Market
- Equities
- OCUL Stock
- News Ocular Therapeutix, Inc.
- Ocular Therapeutix, Inc. announced that it has received $324.999962 million in funding from a group of investors